Pial Artery Supply as an Anatomic Risk Factor for Ischemic Stroke in the Treatment of Intracranial Dural Arteriovenous Fistulas

References

1. 1.↵
   2. Newton TH,
   3. Cronqvist S

   . Involvement of the dural arteries in intra-cranial arteriovenous malformations. Radiology 1969;93:1071–78 doi:10.1148/93.5.1071 pmid:5350675

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Cordonnier C,
   3. Al-Shahi Salman R,
   4. Bhattacharya JJ, et al

   ; IVMS Collaborators. Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study. J Neurol Neurosurg Psychiatry 2008;79:47–51 doi:10.1136/jnnp.2006.113753 pmid:17488785

   Abstract/FREE Full Text
3. 3.↵
   2. Lasjaunias P,
   3. Manelfe C,
   4. Chiu M

   . Angiographic architecture of intracranial vascular malformations and fistulas: pretherapeutic aspects. Neurosurg Rev 1986;9:253–63 doi:10.1007/BF01743632 pmid:3614684

   CrossRefPubMed
4. 4.↵
   2. Singh V,
   3. Smith WS,
   4. Lawton MT, et al

   . Risk factors for hemorrhagic presentation in patients with dural arteriovenous fistulae. Neurosurgery 2008;62:628–35; discussion 628–35 doi:10.1227/01.neu.0000317311.69697.fc pmid:18425010

   CrossRefPubMed
5. 5.↵
   2. Borden JA,
   3. Wu JK,
   4. Shucart WA

   . A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995;82:166–79 doi:10.3171/jns.1995.82.2.0166 pmid:7815143

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Cognard C,
   3. Gobin YP,
   4. Pierot L, et al

   . Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Neuroradiology 1995;194:671–80 doi:10.1148/radiology.194.3.7862961 pmid:7862961

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Atkinson RP,
   3. Awad IA,
   4. Batjer HH, et al

   ; Joint Writing Group of the Technology Assessment Committee American Society of Interventional and Therapeutic Neuroradiology; Joint Section on Cerebrovascular Neurosurgery a Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 2001;32:1430–42 doi:10.1161/01.STR.32.6.1430 pmid:11387510

   Abstract/FREE Full Text
8. 8.↵
   2. Hetts SW,
   3. Tsai T,
   4. Cooke DL, et al

   . Progressive versus nonprogressive intracranial dural arteriovenous fistulas: characteristics and outcomes. AJNR Am J Neuroradiol 2015;36:1912–19 doi:10.3174/ajnr.A4391 pmid:26206813

   Abstract/FREE Full Text
9. 9.↵
   2. Lawton MT,
   3. Kim H,
   4. McCullouch CE, et al

   . A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery 2010;66:702–13; discussion 713 doi:10.1227/01.NEU.0000367555.16733.E1 pmid:20190666

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Spetzler RF,
    3. Martin NA

    . A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83 doi:10.3171/jns.1986.65.4.0476 pmid:3760956

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Hu YC,
    3. Newman CB,
    4. Dashti SR, et al

    . Cranial dural arteriovenous fistula: transarterial Onyx embolization experience and technical nuances. J Neurointerv Surg 2011;3:5–13 doi:10.1136/jnis.2010.003707 pmid:21990779

    Abstract/FREE Full Text
12. 12.↵
    2. Loh Y,
    3. Duckwiler GR

    ; Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: clinical article. J Neurosurg 2010;113:733–41 doi:10.3171/2010.3.JNS09370 pmid:20433277

    CrossRefPubMedWeb of Science
13. 13.↵
    2. McConnell K,
    3. Tjoumakaris S,
    4. Allen J, et al

    . Neuroendovascular management of dural arteriovenous malformations. Neurosurg Clin N Am 2009;20:431–39 doi:10.1016/j.nec.2009.07.014 pmid:19853802

    CrossRefPubMed
14. 14.↵
    2. Signorelli F,
    3. Gory B,
    4. Maduri R, et al

    . Intracranial dural arteriovenous fistulas: a review of current management based on emerging knowledge. J Neurosurg Sci 2017;61:193–206 doi:10.23736/S0390-5616.16.03168-4 pmid:25677401

    CrossRefPubMed
15. 15.↵
    2. Saraf R,
    3. Shrivastava M,
    4. Kumar N, et al

    . Embolization of cranial dural arteriovenous fistulae with ONYX: indications, techniques, and outcomes. Indian J Radiol Imaging 2010;20:26–33 doi:10.4103/0971-3026.59748 pmid:20351988

    CrossRefPubMed
16. 16.↵
    2. Gross BA,
    3. Albuquerque FC,
    4. Moon K, et al

    . Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg 2017;126:1884–93 doi:10.3171/2016.5.JNS16331 pmid:27588586

    CrossRefPubMed
17. 17.↵
    2. Wu Q,
    3. Zhang XS,
    4. Wang HD, et al

    . Onyx embolization for tentorial dural arteriovenous fistula with pial arterial supply: case series and analysis of complications. World Neurosurg 2016;92:58–64 doi:10.1016/j.wneu.2016.04.033 pmid:27108795

    CrossRefPubMed
18. 18.↵
    2. Uranishi R,
    3. Nakase H,
    4. Sakaki T

    . Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 1999;91:781–86 doi:10.3171/jns.1999.91.5.0781 pmid:10541235

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Gupta A,
    3. Periakaruppan A

    . Intracranial dural arteriovenous fistulas: a review. Indian J Radiol Imaging 2009;19:43–48 doi:10.4103/0971-3026.45344 pmid:19774139

    CrossRefPubMed
20. 20.↵
    2. Shin Y,
    3. Nakase H,
    4. Nakamura M, et al

    . Expression of angiogenic growth factor in the rat DAVF model. Neurol Res 2007;29:727–33 doi:10.1179/016164107X208077 pmid:17588308

    CrossRefPubMed
21. 21.↵
    2. Tirakotai W,
    3. Bertalanffy H,
    4. Liu-Guan B, et al

    . Immunohistochemical study in dural arteriovenous fistulas and possible role of local hypoxia for the de novo formation of dural arteriovenous fistulas. Clin Neurol Neurosurg 2005;107:455–60 doi:10.1016/j.clineuro.2004.11.014 pmid:16202817

    CrossRefPubMed
22. 22.↵
    2. Wang SS,
    3. Li CH,
    4. Zhang XJ, et al

    . Investigation of the mechanism of dural arteriovenous fistula formation induced by high intracranial venous pressure in a rabbit model. BMC Neurosci 2014;15:101 doi:10.1186/1471-2202-15-101 pmid:25160131

    CrossRefPubMed
23. 23.↵
    2. Li Q,
    3. Zhang Q,
    4. Huang QH, et al

    . A pivotal role of the vascular endothelial growth factor signaling pathway in the formation of venous hypertension-induced dural arteriovenous fistulas. Mol Med Rep 2014;9:1551–58 doi:10.3892/mmr.2014.2037 pmid:24626343

    CrossRefPubMed
24. 24.↵
    2. Lee JY,
    3. Son YJ,
    4. Kim KE

    . Intracranial pial arteriovenous fistulas. J Korean Neurosurg Soc 2008;44:101–04 doi:10.3340/jkns.2008.44.2.101 pmid:19096703

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Paramasivam S,
    3. Toma N,
    4. Niimi Y, et al

    . De novo development of dural arteriovenous fistula after endovascular embolization of pial arteriovenous fistula. J Neurointerv Surg 2013;5:321–26 doi:10.1136/neurintsurg-2012-010318 pmid:22510457

    Abstract/FREE Full Text
26. 26.↵
    2. Hetts SW,
    3. Keenan K,
    4. Fullterton HJ, et al

    . Pediatric intracranial nongalenic pial arteriovenous fistulas: clinical features, angioarchitecture, and outcomes. AJNR Am J Neuroradiol 2012;33:1710–19 doi:10.3174/ajnr.A3194 pmid:22766672

    Abstract/FREE Full Text
27. 27.↵
    2. Buell TJ,
    3. Ding D,
    4. Starke RM, et al

    . Embolization-induced angiogenesis in cerebral arteriovenous malformations. J Clin Neurosci 2014;21:1866–71 doi:10.1016/j.jocn.2014.04.010 pmid:25001989

    CrossRefPubMed